{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:41:25Z","timestamp":1773992485156,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biomaterials.2020.120338","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T05:33:59Z","timestamp":1598852039000},"page":"120338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"262","author":[{"given":"Changrim","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Peddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andrew","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2020.120338_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17474086.2017.1281122","article-title":"Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic\/dendritic cell neoplasms","author":"Jiang","year":"2017","journal-title":"Expert Rev Hematol 10(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","author":"Campo","year":"2011","journal-title":"Blood 117(19)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fonc.2019.00443","article-title":"Overview of targeted drugs for mature B-cell non-hodgkin lymphomas","volume":"9","author":"Crisci","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.biomaterials.2020.120338_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-018-0402-5","article-title":"Antibody-based therapies for cutaneous T-cell lymphoma","author":"Welborn","year":"2019","journal-title":"Am J Clin Dermatol 20(1)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2009.09.067","article-title":"Immunotherapy of cancer","author":"Borghaei","year":"2009","journal-title":"Eur J Pharmacol 625(1-3)"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120338_bib6","first-page":"30","article-title":"Chemotherapy sensitization by rituximab: experimental and clinical evidence","volume":"27","author":"Wilson","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.biomaterials.2020.120338_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00277-016-2731-x","article-title":"Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma\/leukemia","author":"Burkhardt","year":"2016","journal-title":"Ann Hematol 95(9)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib8","series-title":"Fcgamma receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia, Clin Lymphoma Myeloma Leuk 10(5)","first-page":"347","author":"Zhuang","year":"2010"},{"key":"10.1016\/j.biomaterials.2020.120338_bib9","series-title":"Cytokine release syndrome, J immunother cancer 6(1)","first-page":"56","author":"Shimabukuro-Vornhagen","year":"2018"},{"key":"10.1016\/j.biomaterials.2020.120338_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JOP.200001","article-title":"Review of the safety and feasibility of rapid infusion of rituximab","author":"Atmar","year":"2010","journal-title":"J Oncol Pract 6(2)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10428190500254752","article-title":"Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma","author":"Gutierrez","year":"2006","journal-title":"Leuk Lymphoma 47(1)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2015.11.010","article-title":"Elastin-like polypeptides: therapeutic applications for an emerging class of nanomedicines","volume":"240","author":"Despanie","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120338_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00063","article-title":"Blinatumomab, a Bi-specific anti-CD19\/CD3 BiTE(\u00ae) antibody for the treatment of acute lymphoblastic leukemia: perspectives and current pediatric applications","volume":"4","author":"Hoffman","year":"2014","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.biomaterials.2020.120338_bib14","first-page":"265","article-title":"Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer","author":"Magee","year":"2014","journal-title":"Discovery Medicine 18(100)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcb.240630503","article-title":"T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL)","volume":"24","author":"Bunn","year":"1996","journal-title":"J. Cell. Biochem. Suppl."},{"key":"10.1016\/j.biomaterials.2020.120338_bib16","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","author":"Agar","year":"2010","journal-title":"J Clin Oncol 28(31)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib17","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-08-4631","article-title":"Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death","author":"Klemke","year":"2009","journal-title":"Cancer Res 69(10)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib18","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1002\/adfm.201400715","article-title":"Flipping the switch on clathrin-mediated endocytosis using thermally responsive protein microdomains","author":"Pastuszka","year":"2014","journal-title":"Adv Funct Mater 24(34)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biomaterials.2018.07.063","article-title":"A new temperature-dependent strategy to modulate the epidermal growth factor receptor,","volume":"183","author":"Li","year":"2018","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biomaterials.2020.120338_bib20","doi-asserted-by":"crossref","first-page":"1800112","DOI":"10.1002\/adbi.201800112","article-title":"Tunable assembly of protein-microdomains in living vertebrate embryos","volume":"2","author":"Li","year":"2018","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.biomaterials.2020.120338_bib21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1039\/C3PY00537B","article-title":"A quantitative recipe for engineering protein polymer nanoparticles","author":"Janib","year":"2014","journal-title":"Polym Chem 5(5)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib22","series-title":"A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system, Human antibodies and hybridomas 6(2)","first-page":"57","author":"Hu","year":"1995"},{"key":"10.1016\/j.biomaterials.2020.120338_bib23","first-page":"830","article-title":"2 new monoclonal-antibodies, lym-1 and lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential","author":"Epstein","year":"1987","journal-title":"Cancer Research 47(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib24","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/pro.5560041120","article-title":"How to measure and predict the molar absorption coefficient of a protein","author":"Pace","year":"1995","journal-title":"Protein Sci 4(11)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib25","series-title":"Spectroscopic determination of tryptophan and tyrosine in proteins, Biochemistry 6(7)","first-page":"1948","author":"Edelhoch","year":"1967"},{"key":"10.1016\/j.biomaterials.2020.120338_bib26","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1021\/acs.molpharmaceut.9b00263","article-title":"Berunda polypeptides: biheaded rapamycin carriers for subcutaneous treatment of autoimmune dry eye disease","author":"Lee","year":"2019","journal-title":"Mol Pharm 16(7)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib27","first-page":"2","article-title":"FDA approves new kind of lymphoma treatment","author":"James","year":"1997","journal-title":"Food and Drug Administration, AIDS Treat News (No 284)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.yexcr.2011.03.010","article-title":"Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab","author":"Nagorsen","year":"2011","journal-title":"Exp Cell Res 317(9)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib29","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1021\/jp8062977","article-title":"Effects of Hofmeister anions on the phase transition temperature of elastin-like polypeptides","author":"Cho","year":"2008","journal-title":"J Phys Chem B 112(44)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib30","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1021\/ma011265g","article-title":"Viscosimetric, hydrodynamic, and conformational properties of dendrimers and dendrons","author":"Tande","year":"2001","journal-title":"Macromolecules 34(24)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chroma.2005.11.095","article-title":"Size fractionation and characterization of natural colloids by flow-field flow fractionation coupled to multi-angle laser light scattering","author":"Baalousha","year":"2006","journal-title":"J Chromatogr A 1104(1-2)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1039\/C0AN00738B","article-title":"Characterizing the size, shape, and compactness of a polydisperse prolate ellipsoidal particle via quadruple-detector hydrodynamic chromatography","author":"Brewer","year":"2011","journal-title":"Analyst 136(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib33","series-title":"Preparation of Water-Soluble Polyion Complex (PIC) Micelles Covered with Amphoteric Random Copolymer Shells with Pendant Sulfonate and Quaternary Amino Groups","author":"Nakahata","year":"2018"},{"key":"10.1016\/j.biomaterials.2020.120338_bib34","first-page":"4279","article-title":"Accuracy in multiangle light scattering measurements for molar mass and radius estimations","author":"Andersson","year":"2003","journal-title":"Model calculations and experiments"},{"key":"10.1016\/j.biomaterials.2020.120338_bib35","series-title":"Rituximab (rituxan), AJNR Am J neuroradiol 31(7)","first-page":"1178","author":"Selewski","year":"2010"},{"key":"10.1016\/j.biomaterials.2020.120338_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2818.2008.02059.x","article-title":"A short history of blebbing","author":"Charras","year":"2008","journal-title":"J Microsc 231(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib37","first-page":"139","author":"Cai","year":"1998","journal-title":"Mitochondrial control of apoptosis: the role of cytochrome c, Biochim Biophys Acta 1366(1-2)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib38","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/nn403973g","article-title":"A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody","author":"Aluri","year":"2014","journal-title":"ACS Nano 8(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib39","series-title":"Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors, Cancer Biother Radio 22(3)","first-page":"342","author":"Zhang","year":"2007"},{"key":"10.1016\/j.biomaterials.2020.120338_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.201504137","article-title":"Dynamics of the actin cytoskeleton mediates receptor cross talk: an emerging concept in tuning receptor signaling","author":"Mattila","year":"2016","journal-title":"J Cell Biol 212(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib41","first-page":"1098","author":"Raponi","year":"2011","journal-title":"Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases, Leuk Lymphoma 52(6)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19: a biomarker for B cell development, lymphoma diagnosis and therapy","author":"Wang","year":"2012","journal-title":"Exp Hematol Oncol 1(1)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib43","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3389\/fimmu.2018.03096","article-title":"The coordination between B cell receptor signaling and the actin cytoskeleton during B cell activation,","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120338_bib44","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.4049\/jimmunol.162.12.7088","article-title":"CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation","author":"Fujimoto","year":"1999","journal-title":"J Immunol 162(12)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood.V83.5.1329.1329","article-title":"Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest","author":"Ghetie","year":"1994","journal-title":"Blood 83(5)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib46","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","author":"Willemze","year":"2005","journal-title":"Blood 105(10)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11912-018-0678-x","article-title":"Systemic treatment options for advanced-stage mycosis fungoides and sezary syndrome","author":"Photiou","year":"2018","journal-title":"Curr Oncol Rep 20(4)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib48","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/annonc\/mdx352","article-title":"Global patterns of care in advanced stage mycosis fungoides\/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium","author":"Quaglino","year":"2017","journal-title":"Ann Oncol 28(10)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib49","first-page":"857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","author":"Kim","year":"2003","journal-title":"Arch Dermatol 139(7)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and Sezary syndrome","author":"Hwang","year":"2008","journal-title":"Lancet 371(9616)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib51","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s12325-017-0612-x","article-title":"Rituximab in B-cell hematologic malignancies: a review of 20 Years of clinical experience","author":"Salles","year":"2017","journal-title":"Adv Ther 34(10)"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.120338_bib52","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002820-199712000-00007","article-title":"Side effects of CHOP in the treatment of non-Hodgkin's lymphoma","volume":"20","author":"Sitzia","year":"1997","journal-title":"Canc. Nurs."},{"key":"10.1016\/j.biomaterials.2020.120338_bib53","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood-2011-01-330357","article-title":"Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy","author":"Lim","year":"2011","journal-title":"Blood 118(9)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib54","series-title":"Rituximab resistance, best pract res clin haematol 24(2)","first-page":"203","author":"Rezvani","year":"2011"},{"key":"10.1016\/j.biomaterials.2020.120338_bib55","series-title":"Rituxan nanoconjugation prolongs drug\/cell interaction and enables simultaneous depletion and enhanced Raman detection of lymphoma cells, Journal of Materials Chemistry B 5(26)","first-page":"5165","author":"Yao","year":"2017"},{"key":"10.1016\/j.biomaterials.2020.120338_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/IJN.S185458","article-title":"Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression","volume":"14","author":"Song","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2020.120338_bib57","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acsnano.8b00797","article-title":"Amplification of CD20 cross-linking in rituximab-resistant B-lymphoma cells enhances apoptosis induction by drug-free macromolecular therapeutics","author":"Li","year":"2018","journal-title":"ACS Nano 12(4)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib58","series-title":"Synthetic, cross-linked polypentapeptide fo tropoelastin: an anisotropic, fibrillar elastomer, Biochemistry 15(18)","first-page":"4083","author":"Urry","year":"1976"},{"key":"10.1016\/j.biomaterials.2020.120338_bib59","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2015.08.029","article-title":"Elastin-like polypeptides as models of intrinsically disordered proteins","author":"Roberts","year":"2015","journal-title":"FEBS Lett 589(19 Pt A)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib60","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.addr.2010.04.002","article-title":"Applications of elastin-like polypeptides in tissue engineering","author":"Nettles","year":"2010","journal-title":"Adv Drug Deliv Rev 62(15)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib61","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.actbio.2013.10.001","article-title":"Designing protein-based biomaterials for medical applications","author":"Gagner","year":"2014","journal-title":"Acta Biomater 10(4)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib62","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1038\/s41598-017-03101-4","article-title":"A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity","author":"Sugiyama","year":"2017","journal-title":"Sci Rep 7(1)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib63","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.aad9964","article-title":"Phase separation of signaling molecules promotes T cell receptor signal transduction","author":"Su","year":"2016","journal-title":"Science 352(6285)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41467-018-08064-2","article-title":"TCR microclusters form spatially segregated domains and sequentially assemble in calcium-dependent kinetic steps","author":"Yi","year":"2019","journal-title":"Nat Commun 10(1)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib65","series-title":"Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3, Proc Natl Acad Sci U S A 101(20)","first-page":"7675","author":"Kjer-Nielsen","year":"2004"},{"key":"10.1016\/j.biomaterials.2020.120338_bib66","series-title":"5 Human Albumin, Transfus Med Hemother 36(6)","first-page":"399","year":"2009"},{"key":"10.1016\/j.biomaterials.2020.120338_bib67","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/acs.biomac.9b01431","article-title":"Nanotoxicology of an elastin-like polypeptide rapamycin formulation for breast cancer","author":"Peddi","year":"2020","journal-title":"Biomacromolecules 21(3)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib68","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bm301558q","article-title":"Switchable elastin-like polypeptides that respond to chemical inducers of dimerization","author":"Dhandhukia","year":"2013","journal-title":"Biomacromolecules 14(4)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib69","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.bpj.2018.09.006","article-title":"Effects of doxorubicin on the liquid-liquid phase change properties of elastin-like polypeptides","author":"Zai-Rose","year":"2018","journal-title":"Biophys J 115(8)"},{"key":"10.1016\/j.biomaterials.2020.120338_bib70","series-title":"Human granulocyte-macrophage colony-stimulating factor fused to elastin-like polypeptides assembles biologically-active nanoparticles, bioconjugate chemistry 31(5)","first-page":"1551","author":"Park","year":"2020"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220305846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220305846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:55:03Z","timestamp":1758905703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220305846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":70,"alternative-id":["S0142961220305846"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120338","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptable antibody Nanoworms designed for non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120338"}}